ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC32865-5mg |
|
195987-41-8 |
BMS-214662
|
0 | C25H23N5O2S2 | |
GC32865-1mg |
|
195987-41-8 |
BMS-214662
|
0 | C25H23N5O2S2 | |
GC32865-10mM(1mLinDMSO) |
|
195987-41-8 |
BMS-214662
|
0 | C25H23N5O2S2 | |
GC32864-10mg |
|
2137030-98-7 |
Ensartinib hydrochloride (X-396 hydrochloride)
|
0 | C26H29Cl4FN6O3 | |
GC32864-5mg |
|
2137030-98-7 |
Ensartinib hydrochloride (X-396 hydrochloride)
|
0 | C26H29Cl4FN6O3 | |
GC32864-2mg |
|
2137030-98-7 |
Ensartinib hydrochloride (X-396 hydrochloride)
|
0 | C26H29Cl4FN6O3 | |
GC32863-50mg |
|
1300019-38-8 |
Target Protein-binding moiety 4
|
0 | C20H17ClN4O3 | |
GC32863-10mg |
|
1300019-38-8 |
Target Protein-binding moiety 4
|
0 | C20H17ClN4O3 | |
GC32863-5mg |
|
1300019-38-8 |
Target Protein-binding moiety 4
|
0 | C20H17ClN4O3 | |
GC32863-1mg |
|
1300019-38-8 |
Target Protein-binding moiety 4
|
0 | C20H17ClN4O3 | |
GC32863-10mM(1mLinDMSO) |
|
1300019-38-8 |
Target Protein-binding moiety 4
|
0 | C20H17ClN4O3 | |
GC32862-100mg |
|
328998-53-4 |
inS3-54A18
|
0 | C23H16ClNO2 | |
GC32862-50mg |
|
328998-53-4 |
inS3-54A18
|
0 | C23H16ClNO2 | |
GC32862-10mg |
|
328998-53-4 |
inS3-54A18
|
0 | C23H16ClNO2 | |
GC32862-5mg |
|
328998-53-4 |
inS3-54A18
|
0 | C23H16ClNO2 | |
GC32862-2mg |
|
328998-53-4 |
inS3-54A18
|
0 | C23H16ClNO2 | |
GC32862-10mM(1mLinDMSO) |
|
328998-53-4 |
inS3-54A18
|
0 | C23H16ClNO2 | |
GC32861-100mg |
|
1982372-88-2 |
A-196
|
0 | C18H16Cl2N4 | |
GC32861-50mg |
|
1982372-88-2 |
A-196
|
0 | C18H16Cl2N4 | |
GC32861-10mg |
|
1982372-88-2 |
A-196
|
0 | C18H16Cl2N4 | |